SABS
USDSAB Biotherapeutics Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$3.140
Máximo
$3.330
Mínimo
$3.140
Volumen
0.08M
Fundamentos de la Empresa
Capitalización de Mercado
33.1M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
0.27M
Bolsa
NCM
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
SAB BIO to Present Data at the International Society for Pediatric and Adolescent Diabetes Annual Conference Showcasing Progress in the Development of SAB-142
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (NASDAQ:SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other
SAB BIO to Participate in Upcoming Investor Conferences
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for autoimmune diseases, including its
Acciones Relacionadas
CFFN
Capitol Federal Financial Inc.
STIM
Neuronetics Inc.
DTG
DTE Energy Company 2021 Series E 4.375% Junior Subordinated Debentures
GEHC
GE HealthCare Technologies Inc.
GENE
Genetic Technologies Ltd ADS
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.